How do you taper off Selective Serotonin Reuptake Inhibitors (SSRIs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Safely Taper SSRIs

The most effective approach to tapering SSRIs is to use a hyperbolic tapering schedule with dose reductions of approximately 10% per month, continuing until reaching very low doses before complete discontinuation. 1

Understanding SSRI Withdrawal

SSRI discontinuation syndrome is characterized by physical and psychological symptoms that typically:

  • Begin within 1 week of stopping or reducing medication
  • Resolve spontaneously within 3 weeks if untreated
  • Include dizziness, nausea, lethargy, headache, irritability, anxiety, and sensory disturbances 2

The syndrome occurs because of transient serotonin dysregulation when medication levels decrease too rapidly. Pharmacokinetic differences between SSRIs account for variations in withdrawal severity, with shorter half-life medications (paroxetine) generally causing more pronounced symptoms than longer half-life medications (fluoxetine).

Recommended Tapering Protocol

Step 1: Preparation

  • Assess readiness for discontinuation
  • Choose a period with minimal life stressors
  • Consider switching to fluoxetine before tapering if currently on a short-acting SSRI 3

Step 2: Implement Hyperbolic Tapering

  • Reduce dose by 10% of the original dose per month 1
  • Example for 20mg starting dose:
    • Month 1: 18mg/day (10% reduction)
    • Month 2: 16.2mg/day (another 10% reduction)
    • Month 3: 14.6mg/day
    • Continue this pattern until reaching the smallest available dose

Step 3: Final Phase

  • When reaching the smallest available dose, consider:
    • Taking medication every other day before complete discontinuation
    • Using liquid formulations for more precise dosing at very low doses 3
    • For patients who have taken SSRIs long-term, consider an even slower taper of 5% per month 1

Step 4: Monitoring

  • Schedule follow-up visits at least monthly during the tapering process 1
  • If withdrawal symptoms emerge:
    • Pause the taper at the current dose for 1-2 weeks until symptoms stabilize
    • Resume tapering at a slower rate (5% reduction instead of 10%) 1

Managing Withdrawal Symptoms

If withdrawal symptoms occur despite careful tapering:

Non-pharmacological approaches:

  • Regular exercise
  • Sleep hygiene practices
  • Stress management techniques 1

Pharmacological support (if needed):

  • Trazodone for insomnia and anxiety
  • Hydroxyzine for anxiety and agitation
  • NSAIDs/Acetaminophen for pain symptoms 1

Special Considerations

Medication-specific factors:

  • The FDA label for sertraline notes: "If the decision has been made to discontinue treatment, medication should be tapered, as rapidly as is feasible, but with recognition that abrupt discontinuation can be associated with certain symptoms" 4

Patient-specific factors:

  • Elderly patients require more gradual tapering (5% reduction every 2 weeks) 1
  • Patients with anxiety disorders may benefit from adjunctive treatments during tapering 1
  • For children and adolescents, tapering should be informed by the medication's pharmacokinetic properties 5

Common Pitfalls to Avoid

  1. Tapering too quickly: Guidelines that recommend short tapers of 2-4 weeks show minimal benefits over abrupt discontinuation 3

  2. Not tapering to low enough doses: Successful tapering requires reducing to doses much lower than minimum therapeutic doses 3

  3. Mistaking withdrawal for recurrence: Withdrawal symptoms can be mistaken for recurrence of the underlying disorder, leading to unnecessary long-term medication 3

  4. Abrupt discontinuation: This approach significantly increases the risk of withdrawal symptoms and should be avoided unless a serious adverse effect occurs 4

By following a gradual, hyperbolic tapering schedule with careful monitoring and support for withdrawal symptoms, most patients can successfully discontinue SSRIs while minimizing discomfort and the risk of relapse.

References

Guideline

Tapering Antidepressants and Other Medications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The SSRI discontinuation syndrome.

Journal of psychopharmacology (Oxford, England), 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.